Katharine Sepp, Co-founder & CEO, Oxalys Pharmaceuticals
A $17B/year global leader in automotive technologies, Faurecia is anticipating all the challenges of a changing industry. With the help of strategic partnerships with companies, start-ups and academia within an open innovation ecosystem, Faurecia technologies address two key aspects of mobility: the Cockpit of the Future for a safer, more comfortable, and more intuitive experience in the cockpit of the future, and Sustainable Mobility for cleaner and more environmentally-friendly transportation around the world. Owns more than 300 assembly lines in the US.
2019 MIT Startup Exchange Workshop: Sustainable Materials Innovation
December 3, 2019
MIT Startup Exchange presents its December Startup Workshop, centered around sustainable materials innovation. MIT Startup Exchange works to help create partnerships between over 1,800 MIT-connected startups and industry, represented by MIT Industrial Liaison Program (ILP) members. Today, there is a large and growing societal interest for greater sustainability in the material systems that provide for a modern life style. The call is across all industry sectors, and includes the entire value chain including raw materials, material processing, material uses, and end-of-cycle treatment/reuse. This represents a challenge and an opportunity for companies, and many MIT startups are developing and providing innovative technology and business model solutions. This workshop will present perspectives from industry leaders, academics, and corporate investors, while showcasing several MIT-connected startups in this field.
The Dubai Police will be offering an invitation-only Q&A session for startups to learn more about their collaboration opportunities with MIT-connected startups and to explore potential partnership avenues and resources.
DxLab Inc. (DxLab) is a biotech startup, spun out of MIT and Harvard in September 2020, developing and commercializing a next-generation point-of-care (POC) diagnostic solution for rapid, on-site detection of dangerous pathogens. Combining proprietary platform technology with novel target detection and signal processing methods, we are advancing a pipeline of rapid POC tests.